ANTICORPS ANTI-IL-12/IL-23

• 收藏
• 分享

专利权人:

Teva Pharmaceuticals Australia Pty Ltd

发明人:

申请号：

EP09806241.7

公开号：

EP2326668B1

申请日:

2009.08.14

申请国别(地区):

EP

年份:

2018

代理人:

摘要：

The present invention provides an antibody comprising an antigen binding domain which binds to human IL-12 and human IL-23. The antibody binds human IL-12p40 existing as a monomer (human IL-12p40) and as a homodimer (human IL-12p80) and the antibody inhibits the binding of human IL-12 to human IL-12R beta2 and human IL-23 to human IL-23R but does not inhibit the binding of human IL-12 or human IL-23 or human IL-12p40 or human IL-12p80 to human IL-12Rbeta1.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/